Thrombolytic agents such as tPA (tissue plasminogen activator), streptokinase, and urokinase work by converting plasminogen to plasmin, an enzyme that breaks down fibrin, a key component of blood clots. These drugs are usually administered intravenously and require close monitoring due to the risk of severe bleeding.
